Anika Therapeutics ANIK Income Statements

Conto economico

Quarter End	Dic 2022	Mar 2023	Giu 2023	Set 2023	Dic 2023	Mar 2024	Giu 2024	Set 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	39,62M	37,92M	44,3M	41,47M	42,97M	40,52M	41,92M	38,75M
Reddito operativo	-6,67M	-12,55M	-3,63M	-7,67M	-63,78M	-5,06M	161k	-28,02M
Reddito ante imposte	-6,39M	-12,01M	-3,07M	-7,04M	-63,2M	-4,47M	756k	-27,61M
Reddito netto	-4,91M	-10,35M	-2,74M	-6,58M	-63M	-4,51M	-88k	-29,92M
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	0	0	0	0	0	0	0	0
UTILE OPERATIVO	-6,67M	-12,55M	-3,63M	-7,67M	-63,78M	-5,06M	161k	-28,02M
EBITDA	-3M	-9M	-81k	-4,13M	1,98M	-3M	2,22M	-22,73M

Fine anno 31 Dicembre 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	103,38M	113,42M	105,56M	114,61M	159,12M	168,89M	156,24M	166,66M
Reddito operativo	50,61M	45,73M	21,75M	34,25M	-28,32M	2,62M	-19,4M	-87,64M
Reddito ante imposte	50,87M	46,2M	23,21M	36,12M	-28,62M	2,43M	-18,75M	-85,33M
Reddito netto	32,55M	31,82M	18,72M	27,19M	-23,98M	4,13M	-14,86M	-82,67M
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	2.225	2.166	1.318	1.901	-1.674	0.286	-1.016	-5.65
UTILE OPERATIVO	50,61M	45,73M	21,75M	34,25M	-28,32M	2,62M	-19,4M	-87,64M
EBITDA	54,34M	50,02M	27,66M	40,63M	27,66M	16,95M	-4,91M	-11,23M